The Women's Health Initiative: evolving insights over 15 years.

[1]  A. LaCroix,et al.  The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women , 2017, Menopause.

[2]  B. Howard,et al.  Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials , 2017, Menopause.

[3]  B. Howard,et al.  Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study , 2015, Menopause.

[4]  Lewis H Kuller,et al.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. , 2013, JAMA.

[5]  K. Matthews,et al.  Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation , 2011, Menopause.

[6]  J. Manson,et al.  Vasomotor symptoms and cardiovascular events in postmenopausal women , 2011, Menopause.

[7]  J. Manson,et al.  Vasomotor symptoms and coronary artery calcium in postmenopausal women , 2010, Menopause.

[8]  G. Chrousos,et al.  Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. , 2010, The Journal of clinical endocrinology and metabolism.

[9]  E. Barrett-Connor,et al.  Vasomotor symptoms and mortality: the Rancho Bernardo Study , 2009, Menopause.

[10]  E. Vittinghoff,et al.  Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women , 2009, Menopause.

[11]  J. Manson,et al.  Using Basic Science to Design a Clinical Trial: Baseline Characteristics of Women Enrolled in the Kronos Early Estrogen Prevention Study (KEEPS) , 2009, Journal of cardiovascular translational research.

[12]  M. Rönnback,et al.  Evidence for a Role of Hot Flushes in Vascular Function in Recently Postmenopausal Women , 2009, Obstetrics and gynecology.

[13]  M. Ferraz,et al.  Clinical risk factors for osteoporotic fractures in Brazilian women and men: the Brazilian Osteoporosis Study (BRAZOS) , 2009, Osteoporosis International.

[14]  K. Matthews,et al.  Hot Flashes and Subclinical Cardiovascular Disease: Findings From the Study of Women’s Health Across the Nation Heart Study , 2008, Circulation.

[15]  D. Grobbee,et al.  Menopausal Complaints Are Associated With Cardiovascular Risk Factors , 2008, Hypertension.

[16]  M. Boscaro,et al.  Effect of natural early menopause on bone mineral density. , 2008, Maturitas.

[17]  L. Shulman.  Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause , 2008 .

[18]  J. Schwartz,et al.  Hot flashes are associated with increased ambulatory systolic blood pressure , 2007, Menopause.

[19]  J. Manson,et al.  Conjugated equine estrogens and coronary heart disease : The women's health initiative , 2006 .

[20]  J. Manson,et al.  Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.

[21]  P. Galuppo,et al.  Different rates of forearm bone loss in healthy women with early or late menopause , 2005, Osteoporosis International.

[22]  A. Hofman,et al.  Risk Factors for Incident Vertebral Fractures in Men and Women: The Rotterdam Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  A. LaCroix,et al.  Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. , 2003, JAMA.

[24]  Mary Cushman,et al.  Estrogen plus progestin and the risk of coronary heart disease. , 2003, The New England journal of medicine.

[25]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[26]  O Johnell,et al.  Bone loss in relation to menopause: a prospective study during 16 years. , 2001, Bone.

[27]  B. Henderson,et al.  Decreased Mortality in Users of Estrogen Replacement Therapy , 1991, Archives of internal medicine.

[28]  J. Madans,et al.  Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. , 1991, American journal of obstetrics and gynecology.

[29]  G. Colditz,et al.  Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆ , 1991 .

[30]  E. Barrett-Connor,et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.

[31]  J. Buwalda,et al.  Age of the , 1927 .